AVITA Medical(RCEL) - 2025 Q4 - Earnings Call Transcript

AVITA Medical (NasdaqCM:RCEL) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Company ParticipantsBen Atkins - VP of Investor RelationsCary Vance - Interim CEODavid O'Toole - CFOConference Call ParticipantsIan Arndt - Equity Research AnalystJosh Jennings - Equity Research AnalystRyan Zimmerman - Equity Research AnalystOperatorday, and thank you for standing by. Welcome to the AVITA Medical, Inc. fourth quarter and full year 2025 earnings conference call. At this time, all participants are in listen-only ...